Af Ablation In Brady-Tachy Syndrome

Status

Terminated

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00740272

Acronym

Alternative

Enrollment

Registered

2008-08-22

Start date

2008-03-31

Completion date

2009-12-31

Last updated

2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brady-tachy Syndrome

Keywords

brady-tachy syndrome, AF ablation

Brief summary

The aim of the study is to evaluate the impact of atrial fibrillation ablation in patients presenting a brady-tachy syndrome on the AF burden. The hypothesis of the study is that AF ablation prevents not only from AF episodes recurrence but also from bradycardic episodes.

Detailed description

The study is a randomized study 1:1 AF ablation vs non AF ablation. Patients are followed for 1 year. 38 patients will be required to show a significant reduction in AF burden.

Interventions

PROCEDUREAF ablation + pacemaker implantation

regular pacemaker implantation and concomitant AF ablation procedure (PV isolation)

PROCEDUREPacemaker implantation

regular pacemaker implantation

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* paroxystic AF * symptomatic pauses (\>5s at night or 3s during daytime)

Exclusion criteria

* permanent AF * age \> 80 y * pregnant women * minors

Design outcomes

Primary

Measure	Time frame
AF burden	1 year

Secondary

Measure	Time frame
Quality of life	1 year

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026